The default estimated percentages shown for 2015 and 2016 are based on expert opinion of anticipated treatment rates. You may alter the percentages based on your own assumptions (knowing your percentage of HCV members treated each year and your specific HCV risk).

Using January – June book of business (BoB) data, the percent treated for the BoB was estimated at 5%. Higher risk clients may need to use higher treated percentages, while lower risk clients may choose lower percentages. However, given the novel nature of the latest hepatitis C medications, there is no available literature of actual experience on which to base treatment rates at this time. When making plan-specific assumptions, consider the impact of implemented or planned utilization management programs.